nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0262	0.0363	CbGbCtD
Trimipramine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0246	0.0342	CbGbCtD
Trimipramine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0223	0.0309	CbGbCtD
Trimipramine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0223	0.0309	CbGbCtD
Trimipramine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0218	0.0302	CbGbCtD
Trimipramine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0205	0.0284	CbGbCtD
Trimipramine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0205	0.0284	CbGbCtD
Trimipramine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0199	0.0276	CbGbCtD
Trimipramine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0199	0.0276	CbGbCtD
Trimipramine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0192	0.0267	CbGbCtD
Trimipramine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0187	0.026	CbGbCtD
Trimipramine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0187	0.026	CbGbCtD
Trimipramine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0187	0.0259	CbGbCtD
Trimipramine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0185	0.0257	CbGbCtD
Trimipramine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0185	0.0257	CbGbCtD
Trimipramine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.018	0.0249	CbGbCtD
Trimipramine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0169	0.0235	CbGbCtD
Trimipramine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0169	0.0235	CbGbCtD
Trimipramine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0169	0.0234	CbGbCtD
Trimipramine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0169	0.0234	CbGbCtD
Trimipramine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0162	0.0224	CbGbCtD
Trimipramine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.016	0.0222	CbGbCtD
Trimipramine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0155	0.0215	CbGbCtD
Trimipramine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0155	0.0215	CbGbCtD
Trimipramine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0151	0.0209	CbGbCtD
Trimipramine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0146	0.0203	CbGbCtD
Trimipramine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0142	0.0197	CbGbCtD
Trimipramine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.014	0.0195	CbGbCtD
Trimipramine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.014	0.0195	CbGbCtD
Trimipramine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0136	0.0189	CbGbCtD
Trimipramine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0136	0.0189	CbGbCtD
Trimipramine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0135	0.0187	CbGbCtD
Trimipramine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0131	0.0181	CbGbCtD
Trimipramine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0128	0.0178	CbGbCtD
Trimipramine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0128	0.0178	CbGbCtD
Trimipramine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0127	0.0176	CbGbCtD
Trimipramine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0119	0.0165	CbGbCtD
Trimipramine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0119	0.0165	CbGbCtD
Trimipramine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0108	0.0149	CbGbCtD
Trimipramine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0108	0.0149	CbGbCtD
Trimipramine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0101	0.014	CbGbCtD
Trimipramine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0093	0.0129	CbGbCtD
Trimipramine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00903	0.0125	CbGbCtD
Trimipramine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00817	0.0113	CbGbCtD
Trimipramine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00817	0.0113	CbGbCtD
Trimipramine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00783	0.0109	CbGbCtD
Trimipramine—HTR3A—nerve—acquired immunodeficiency syndrome	0.00276	0.0486	CbGeAlD
Trimipramine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00229	0.0405	CbGeAlD
Trimipramine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00185	0.0326	CbGeAlD
Trimipramine—DRD2—nerve—acquired immunodeficiency syndrome	0.00169	0.0297	CbGeAlD
Trimipramine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00159	0.028	CbGeAlD
Trimipramine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00141	0.0249	CbGeAlD
Trimipramine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00132	0.0232	CbGeAlD
Trimipramine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00111	0.0196	CbGeAlD
Trimipramine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00102	0.018	CbGeAlD
Trimipramine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000989	0.0175	CbGeAlD
Trimipramine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000947	0.0167	CbGeAlD
Trimipramine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000841	0.0148	CbGeAlD
Trimipramine—HTR3A—digestive system—acquired immunodeficiency syndrome	0.000801	0.0141	CbGeAlD
Trimipramine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000778	0.0137	CbGeAlD
Trimipramine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000766	0.0135	CbGeAlD
Trimipramine—HTR3A—blood—acquired immunodeficiency syndrome	0.000763	0.0135	CbGeAlD
Trimipramine—DRD2—retina—acquired immunodeficiency syndrome	0.000698	0.0123	CbGeAlD
Trimipramine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000688	0.0121	CbGeAlD
Trimipramine—HTR3A—lung—acquired immunodeficiency syndrome	0.000669	0.0118	CbGeAlD
Trimipramine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000663	0.0117	CbGeAlD
Trimipramine—HTR3A—nervous system—acquired immunodeficiency syndrome	0.00062	0.0109	CbGeAlD
Trimipramine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000612	0.0108	CbGeAlD
Trimipramine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000611	0.0108	CbGeAlD
Trimipramine—HTR3A—central nervous system—acquired immunodeficiency syndrome	0.000597	0.0105	CbGeAlD
Trimipramine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000592	0.0104	CbGeAlD
Trimipramine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000582	0.0103	CbGeAlD
Trimipramine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000561	0.0099	CbGeAlD
Trimipramine—SLC6A3—lung—acquired immunodeficiency syndrome	0.000557	0.00983	CbGeAlD
Trimipramine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000551	0.00972	CbGeAlD
Trimipramine—ADRA1B—brain—acquired immunodeficiency syndrome	0.000526	0.00929	CbGeAlD
Trimipramine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000516	0.0091	CbGeAlD
Trimipramine—SLC6A4—lung—acquired immunodeficiency syndrome	0.00051	0.00901	CbGeAlD
Trimipramine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000506	0.00894	CbGeAlD
Trimipramine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000506	0.00894	CbGeAlD
Trimipramine—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000503	0.00888	CbGeAlD
Trimipramine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000498	0.0088	CbGeAlD
Trimipramine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000498	0.00879	CbGeAlD
Trimipramine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000496	0.00876	CbGeAlD
Trimipramine—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000485	0.00855	CbGeAlD
Trimipramine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000482	0.00851	CbGeAlD
Trimipramine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.00048	0.00847	CbGeAlD
Trimipramine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000476	0.00841	CbGeAlD
Trimipramine—HTR3A—brain—acquired immunodeficiency syndrome	0.000474	0.00836	CbGeAlD
Trimipramine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000472	0.00834	CbGeAlD
Trimipramine—HTR2A—retina—acquired immunodeficiency syndrome	0.00046	0.00813	CbGeAlD
Trimipramine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000455	0.00803	CbGeAlD
Trimipramine—SLC6A2—lung—acquired immunodeficiency syndrome	0.000449	0.00793	CbGeAlD
Trimipramine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000447	0.00789	CbGeAlD
Trimipramine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.00042	0.0074	CbGeAlD
Trimipramine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000416	0.00734	CbGeAlD
Trimipramine—DRD2—lung—acquired immunodeficiency syndrome	0.000409	0.00723	CbGeAlD
Trimipramine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000404	0.00713	CbGeAlD
Trimipramine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.0004	0.00707	CbGeAlD
Trimipramine—SLC6A3—brain—acquired immunodeficiency syndrome	0.000394	0.00696	CbGeAlD
Trimipramine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000392	0.00693	CbGeAlD
Trimipramine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000387	0.00683	CbGeAlD
Trimipramine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000387	0.00683	CbGeAlD
Trimipramine—HTR1D—brain—acquired immunodeficiency syndrome	0.000385	0.00679	CbGeAlD
Trimipramine—HTR2C—brain—acquired immunodeficiency syndrome	0.000381	0.00672	CbGeAlD
Trimipramine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000379	0.00669	CbGeAlD
Trimipramine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000374	0.0066	CbGeAlD
Trimipramine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000372	0.00657	CbGeAlD
Trimipramine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000365	0.00644	CbGeAlD
Trimipramine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000362	0.00639	CbGeAlD
Trimipramine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000361	0.00637	CbGeAlD
Trimipramine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000349	0.00616	CbGeAlD
Trimipramine—HRH1—vagina—acquired immunodeficiency syndrome	0.000342	0.00603	CbGeAlD
Trimipramine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000336	0.00593	CbGeAlD
Trimipramine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000323	0.00571	CbGeAlD
Trimipramine—HRH1—lung—acquired immunodeficiency syndrome	0.000323	0.00571	CbGeAlD
Trimipramine—HTR1A—brain—acquired immunodeficiency syndrome	0.000321	0.00566	CbGeAlD
Trimipramine—SLC6A2—brain—acquired immunodeficiency syndrome	0.000318	0.00561	CbGeAlD
Trimipramine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000318	0.0056	CbGeAlD
Trimipramine—HTR2A—blood—acquired immunodeficiency syndrome	0.000308	0.00544	CbGeAlD
Trimipramine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000307	0.00542	CbGeAlD
Trimipramine—ABCB1—retina—acquired immunodeficiency syndrome	0.000302	0.00533	CbGeAlD
Trimipramine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000299	0.00528	CbGeAlD
Trimipramine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000299	0.00528	CbGeAlD
Trimipramine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000297	0.00524	CbGeAlD
Trimipramine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000296	0.00522	CbGeAlD
Trimipramine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000295	0.0052	CbGeAlD
Trimipramine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000294	0.00519	CbGeAlD
Trimipramine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000293	0.00148	CcSEcCtD
Trimipramine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000293	0.00148	CcSEcCtD
Trimipramine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000292	0.00147	CcSEcCtD
Trimipramine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.00147	CcSEcCtD
Trimipramine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000291	0.00147	CcSEcCtD
Trimipramine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00029	0.00146	CcSEcCtD
Trimipramine—DRD2—brain—acquired immunodeficiency syndrome	0.00029	0.00511	CbGeAlD
Trimipramine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000289	0.00146	CcSEcCtD
Trimipramine—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.00146	CcSEcCtD
Trimipramine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.00146	CcSEcCtD
Trimipramine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000289	0.00146	CcSEcCtD
Trimipramine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000289	0.00146	CcSEcCtD
Trimipramine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000289	0.00146	CcSEcCtD
Trimipramine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000288	0.00509	CbGeAlD
Trimipramine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000288	0.00145	CcSEcCtD
Trimipramine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.00144	CcSEcCtD
Trimipramine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000286	0.00144	CcSEcCtD
Trimipramine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.00144	CcSEcCtD
Trimipramine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000286	0.00144	CcSEcCtD
Trimipramine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000286	0.00144	CcSEcCtD
Trimipramine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000285	0.00504	CbGeAlD
Trimipramine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000285	0.00503	CbGeAlD
Trimipramine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000285	0.00144	CcSEcCtD
Trimipramine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000284	0.00143	CcSEcCtD
Trimipramine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000283	0.005	CbGeAlD
Trimipramine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.00142	CcSEcCtD
Trimipramine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00142	CcSEcCtD
Trimipramine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000281	0.00495	CbGeAlD
Trimipramine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00028	0.00141	CcSEcCtD
Trimipramine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.00141	CcSEcCtD
Trimipramine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000278	0.0014	CcSEcCtD
Trimipramine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000278	0.0014	CcSEcCtD
Trimipramine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000277	0.0014	CcSEcCtD
Trimipramine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000277	0.0014	CcSEcCtD
Trimipramine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000277	0.0014	CcSEcCtD
Trimipramine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000276	0.00139	CcSEcCtD
Trimipramine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000276	0.00139	CcSEcCtD
Trimipramine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000276	0.00139	CcSEcCtD
Trimipramine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.00139	CcSEcCtD
Trimipramine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000276	0.00139	CcSEcCtD
Trimipramine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000274	0.00138	CcSEcCtD
Trimipramine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.00138	CcSEcCtD
Trimipramine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000272	0.00137	CcSEcCtD
Trimipramine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000272	0.00137	CcSEcCtD
Trimipramine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.00137	CcSEcCtD
Trimipramine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.00137	CcSEcCtD
Trimipramine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000271	0.00137	CcSEcCtD
Trimipramine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000271	0.00137	CcSEcCtD
Trimipramine—HTR2A—lung—acquired immunodeficiency syndrome	0.00027	0.00477	CbGeAlD
Trimipramine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00027	0.00136	CcSEcCtD
Trimipramine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000269	0.00136	CcSEcCtD
Trimipramine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000269	0.00136	CcSEcCtD
Trimipramine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000269	0.00136	CcSEcCtD
Trimipramine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000268	0.00135	CcSEcCtD
Trimipramine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000267	0.00134	CcSEcCtD
Trimipramine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000266	0.00134	CcSEcCtD
Trimipramine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000266	0.00134	CcSEcCtD
Trimipramine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000266	0.00134	CcSEcCtD
Trimipramine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.00134	CcSEcCtD
Trimipramine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000266	0.00134	CcSEcCtD
Trimipramine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.00134	CcSEcCtD
Trimipramine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000265	0.00134	CcSEcCtD
Trimipramine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000264	0.00133	CcSEcCtD
Trimipramine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.00133	CcSEcCtD
Trimipramine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000264	0.00133	CcSEcCtD
Trimipramine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000263	0.00133	CcSEcCtD
Trimipramine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000263	0.00132	CcSEcCtD
Trimipramine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000262	0.00132	CcSEcCtD
Trimipramine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000262	0.00132	CcSEcCtD
Trimipramine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00132	CcSEcCtD
Trimipramine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000261	0.00131	CcSEcCtD
Trimipramine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00131	CcSEcCtD
Trimipramine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000258	0.0013	CcSEcCtD
Trimipramine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000258	0.0013	CcSEcCtD
Trimipramine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000258	0.0013	CcSEcCtD
Trimipramine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.0013	CcSEcCtD
Trimipramine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00129	CcSEcCtD
Trimipramine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.00129	CcSEcCtD
Trimipramine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000256	0.00129	CcSEcCtD
Trimipramine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.00129	CcSEcCtD
Trimipramine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000256	0.00129	CcSEcCtD
Trimipramine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.00129	CcSEcCtD
Trimipramine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000255	0.00128	CcSEcCtD
Trimipramine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000255	0.00128	CcSEcCtD
Trimipramine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000254	0.00128	CcSEcCtD
Trimipramine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.00128	CcSEcCtD
Trimipramine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000254	0.00128	CcSEcCtD
Trimipramine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000254	0.00128	CcSEcCtD
Trimipramine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000254	0.00128	CcSEcCtD
Trimipramine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.00128	CcSEcCtD
Trimipramine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.00127	CcSEcCtD
Trimipramine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000252	0.00127	CcSEcCtD
Trimipramine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00126	CcSEcCtD
Trimipramine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000251	0.00126	CcSEcCtD
Trimipramine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00025	0.00441	CbGeAlD
Trimipramine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00025	0.00126	CcSEcCtD
Trimipramine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000249	0.00126	CcSEcCtD
Trimipramine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.00125	CcSEcCtD
Trimipramine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000247	0.00124	CcSEcCtD
Trimipramine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000246	0.00124	CcSEcCtD
Trimipramine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000246	0.00124	CcSEcCtD
Trimipramine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000246	0.00124	CcSEcCtD
Trimipramine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00124	CcSEcCtD
Trimipramine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000245	0.00124	CcSEcCtD
Trimipramine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.00124	CcSEcCtD
Trimipramine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00123	CcSEcCtD
Trimipramine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.00123	CcSEcCtD
Trimipramine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000244	0.00123	CcSEcCtD
Trimipramine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.00123	CcSEcCtD
Trimipramine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.00123	CcSEcCtD
Trimipramine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00123	CcSEcCtD
Trimipramine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00122	CcSEcCtD
Trimipramine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000242	0.00122	CcSEcCtD
Trimipramine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000242	0.00122	CcSEcCtD
Trimipramine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000242	0.00122	CcSEcCtD
Trimipramine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.00122	CcSEcCtD
Trimipramine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.00121	CcSEcCtD
Trimipramine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000241	0.00425	CbGeAlD
Trimipramine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000241	0.00121	CcSEcCtD
Trimipramine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.00121	CcSEcCtD
Trimipramine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.0012	CcSEcCtD
Trimipramine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000238	0.0012	CcSEcCtD
Trimipramine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000238	0.0012	CcSEcCtD
Trimipramine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.0012	CcSEcCtD
Trimipramine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000237	0.00119	CcSEcCtD
Trimipramine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000237	0.00119	CcSEcCtD
Trimipramine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.00119	CcSEcCtD
Trimipramine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.00119	CcSEcCtD
Trimipramine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000236	0.00119	CcSEcCtD
Trimipramine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.00119	CcSEcCtD
Trimipramine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.00118	CcSEcCtD
Trimipramine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Trimipramine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Trimipramine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Trimipramine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Trimipramine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Trimipramine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Trimipramine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.00118	CcSEcCtD
Trimipramine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000233	0.00117	CcSEcCtD
Trimipramine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000232	0.00117	CcSEcCtD
Trimipramine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000232	0.00117	CcSEcCtD
Trimipramine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.00117	CcSEcCtD
Trimipramine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00117	CcSEcCtD
Trimipramine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000231	0.00409	CbGeAlD
Trimipramine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000231	0.00117	CcSEcCtD
Trimipramine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00023	0.00116	CcSEcCtD
Trimipramine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00023	0.00116	CcSEcCtD
Trimipramine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00116	CcSEcCtD
Trimipramine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.00116	CcSEcCtD
Trimipramine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000229	0.00115	CcSEcCtD
Trimipramine—HRH1—brain—acquired immunodeficiency syndrome	0.000229	0.00404	CbGeAlD
Trimipramine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000228	0.00115	CcSEcCtD
Trimipramine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.00115	CcSEcCtD
Trimipramine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000228	0.00402	CbGeAlD
Trimipramine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.00114	CcSEcCtD
Trimipramine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.00114	CcSEcCtD
Trimipramine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.00114	CcSEcCtD
Trimipramine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.00113	CcSEcCtD
Trimipramine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.00113	CcSEcCtD
Trimipramine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000225	0.00397	CbGeAlD
Trimipramine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.00113	CcSEcCtD
Trimipramine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.00113	CcSEcCtD
Trimipramine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.00113	CcSEcCtD
Trimipramine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000223	0.00393	CbGeAlD
Trimipramine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.00112	CcSEcCtD
Trimipramine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000221	0.0039	CbGeAlD
Trimipramine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000221	0.00111	CcSEcCtD
Trimipramine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.00111	CcSEcCtD
Trimipramine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00022	0.00111	CcSEcCtD
Trimipramine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00022	0.00111	CcSEcCtD
Trimipramine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000219	0.00387	CbGeAlD
Trimipramine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.00111	CcSEcCtD
Trimipramine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.0011	CcSEcCtD
Trimipramine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.0011	CcSEcCtD
Trimipramine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000217	0.00383	CbGeAlD
Trimipramine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000217	0.00109	CcSEcCtD
Trimipramine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.00109	CcSEcCtD
Trimipramine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.00109	CcSEcCtD
Trimipramine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.00108	CcSEcCtD
Trimipramine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000215	0.00108	CcSEcCtD
Trimipramine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.00108	CcSEcCtD
Trimipramine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000214	0.00379	CbGeAlD
Trimipramine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.00108	CcSEcCtD
Trimipramine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00108	CcSEcCtD
Trimipramine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.00108	CcSEcCtD
Trimipramine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.00108	CcSEcCtD
Trimipramine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000213	0.00107	CcSEcCtD
Trimipramine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.00107	CcSEcCtD
Trimipramine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000212	0.00107	CcSEcCtD
Trimipramine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000212	0.00374	CbGeAlD
Trimipramine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.00106	CcSEcCtD
Trimipramine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.00105	CcSEcCtD
Trimipramine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.00105	CcSEcCtD
Trimipramine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.00104	CcSEcCtD
Trimipramine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.00104	CcSEcCtD
Trimipramine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00104	CcSEcCtD
Trimipramine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000205	0.00103	CcSEcCtD
Trimipramine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.00103	CcSEcCtD
Trimipramine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.00103	CcSEcCtD
Trimipramine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000203	0.00102	CcSEcCtD
Trimipramine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.00102	CcSEcCtD
Trimipramine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000203	0.00102	CcSEcCtD
Trimipramine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00102	CcSEcCtD
Trimipramine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.00102	CcSEcCtD
Trimipramine—ABCB1—blood—acquired immunodeficiency syndrome	0.000202	0.00356	CbGeAlD
Trimipramine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.00101	CcSEcCtD
Trimipramine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.00101	CcSEcCtD
Trimipramine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.001	CcSEcCtD
Trimipramine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.001	CcSEcCtD
Trimipramine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.001	CcSEcCtD
Trimipramine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000198	0.000999	CcSEcCtD
Trimipramine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000998	CcSEcCtD
Trimipramine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000998	CcSEcCtD
Trimipramine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000992	CcSEcCtD
Trimipramine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000195	0.00345	CbGeAlD
Trimipramine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000194	0.00343	CbGeAlD
Trimipramine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.00098	CcSEcCtD
Trimipramine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.000977	CcSEcCtD
Trimipramine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000966	CcSEcCtD
Trimipramine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000966	CcSEcCtD
Trimipramine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000191	0.000965	CcSEcCtD
Trimipramine—HTR2A—brain—acquired immunodeficiency syndrome	0.000191	0.00337	CbGeAlD
Trimipramine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000961	CcSEcCtD
Trimipramine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000961	CcSEcCtD
Trimipramine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000191	0.00096	CcSEcCtD
Trimipramine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000956	CcSEcCtD
Trimipramine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000189	0.000952	CcSEcCtD
Trimipramine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000189	0.000952	CcSEcCtD
Trimipramine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000946	CcSEcCtD
Trimipramine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.000944	CcSEcCtD
Trimipramine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000187	0.0033	CbGeAlD
Trimipramine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.000934	CcSEcCtD
Trimipramine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000921	CcSEcCtD
Trimipramine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000917	CcSEcCtD
Trimipramine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000917	CcSEcCtD
Trimipramine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000907	CcSEcCtD
Trimipramine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000906	CcSEcCtD
Trimipramine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000903	CcSEcCtD
Trimipramine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.0009	CcSEcCtD
Trimipramine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000899	CcSEcCtD
Trimipramine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000178	0.000897	CcSEcCtD
Trimipramine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000894	CcSEcCtD
Trimipramine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000893	CcSEcCtD
Trimipramine—ABCB1—lung—acquired immunodeficiency syndrome	0.000177	0.00312	CbGeAlD
Trimipramine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000174	0.00307	CbGeAlD
Trimipramine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000872	CcSEcCtD
Trimipramine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000868	CcSEcCtD
Trimipramine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000864	CcSEcCtD
Trimipramine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000861	CcSEcCtD
Trimipramine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.00086	CcSEcCtD
Trimipramine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.00086	CcSEcCtD
Trimipramine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000856	CcSEcCtD
Trimipramine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000848	CcSEcCtD
Trimipramine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000835	CcSEcCtD
Trimipramine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000832	CcSEcCtD
Trimipramine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000832	CcSEcCtD
Trimipramine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000164	0.00289	CbGeAlD
Trimipramine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.00082	CcSEcCtD
Trimipramine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000811	CcSEcCtD
Trimipramine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000804	CcSEcCtD
Trimipramine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000803	CcSEcCtD
Trimipramine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000796	CcSEcCtD
Trimipramine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000796	CcSEcCtD
Trimipramine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000158	0.00278	CbGeAlD
Trimipramine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000793	CcSEcCtD
Trimipramine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000791	CcSEcCtD
Trimipramine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000773	CcSEcCtD
Trimipramine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000767	CcSEcCtD
Trimipramine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000766	CcSEcCtD
Trimipramine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000766	CcSEcCtD
Trimipramine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000761	CcSEcCtD
Trimipramine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.00075	CcSEcCtD
Trimipramine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000737	CcSEcCtD
Trimipramine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000731	CcSEcCtD
Trimipramine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.00073	CcSEcCtD
Trimipramine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000726	CcSEcCtD
Trimipramine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000722	CcSEcCtD
Trimipramine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000689	CcSEcCtD
Trimipramine—ABCB1—brain—acquired immunodeficiency syndrome	0.000125	0.00221	CbGeAlD
Trimipramine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000121	0.00214	CbGeAlD
Trimipramine—Oxcarbazepine—ALB—acquired immunodeficiency syndrome	0.000111	0.272	CrCbGaD
Trimipramine—Acepromazine—ALB—acquired immunodeficiency syndrome	8.39e-05	0.206	CrCbGaD
Trimipramine—Clomipramine—ALB—acquired immunodeficiency syndrome	6.38e-05	0.156	CrCbGaD
Trimipramine—Nortriptyline—ALB—acquired immunodeficiency syndrome	6.23e-05	0.153	CrCbGaD
Trimipramine—Chlorpromazine—ALB—acquired immunodeficiency syndrome	4.38e-05	0.107	CrCbGaD
Trimipramine—Amitriptyline—ALB—acquired immunodeficiency syndrome	4.33e-05	0.106	CrCbGaD
Trimipramine—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.98e-05	0.000857	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.97e-05	0.000854	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.97e-05	0.000854	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.94e-05	0.000841	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.94e-05	0.000841	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.93e-05	0.000839	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.93e-05	0.000839	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.93e-05	0.000838	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.93e-05	0.000837	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.93e-05	0.000837	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.9e-05	0.000824	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.9e-05	0.000824	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.9e-05	0.000823	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.9e-05	0.000823	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.9e-05	0.000823	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.9e-05	0.000823	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.89e-05	0.000821	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.89e-05	0.000821	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	1.87e-05	0.000811	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.86e-05	0.000808	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.86e-05	0.000806	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.86e-05	0.000806	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.86e-05	0.000806	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.84e-05	0.0008	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.84e-05	0.000797	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.83e-05	0.000795	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.83e-05	0.000795	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.83e-05	0.000793	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.82e-05	0.000791	CbGpPWpGaD
Trimipramine—SLC6A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.81e-05	0.000787	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.8e-05	0.000779	CbGpPWpGaD
Trimipramine—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.79e-05	0.000777	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.78e-05	0.000773	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.76e-05	0.000765	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.76e-05	0.000765	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—ALB—acquired immunodeficiency syndrome	1.76e-05	0.000763	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.75e-05	0.00076	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.75e-05	0.00076	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.75e-05	0.00076	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.75e-05	0.000759	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.73e-05	0.000751	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.73e-05	0.000749	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.73e-05	0.000749	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.72e-05	0.000748	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.72e-05	0.000748	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.72e-05	0.000746	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.72e-05	0.000746	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.72e-05	0.000746	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.72e-05	0.000744	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.71e-05	0.00074	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.7e-05	0.000739	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.69e-05	0.000732	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.69e-05	0.000732	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.68e-05	0.000729	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.67e-05	0.000725	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.67e-05	0.000723	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.66e-05	0.000721	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.65e-05	0.000714	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.64e-05	0.00071	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.61e-05	0.000697	CbGpPWpGaD
Trimipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.6e-05	0.000692	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.6e-05	0.000692	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.59e-05	0.00069	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.58e-05	0.000685	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.58e-05	0.000685	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.57e-05	0.000682	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.57e-05	0.00068	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.57e-05	0.00068	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.57e-05	0.00068	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.000677	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.55e-05	0.000672	CbGpPWpGaD
Trimipramine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.53e-05	0.000663	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.52e-05	0.000658	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.51e-05	0.000655	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.51e-05	0.000653	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.5e-05	0.00065	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.5e-05	0.000648	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.49e-05	0.000645	CbGpPWpGaD
Trimipramine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.49e-05	0.000645	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.47e-05	0.000636	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.45e-05	0.000627	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.45e-05	0.000627	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.44e-05	0.000626	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.44e-05	0.000625	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.44e-05	0.000623	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.43e-05	0.000622	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000619	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.42e-05	0.000618	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.42e-05	0.000617	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.42e-05	0.000616	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.42e-05	0.000614	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.41e-05	0.000613	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.39e-05	0.000604	CbGpPWpGaD
Trimipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.39e-05	0.000601	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.39e-05	0.000601	CbGpPWpGaD
Trimipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.38e-05	0.0006	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.38e-05	0.000598	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.37e-05	0.000593	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.36e-05	0.00059	CbGpPWpGaD
Trimipramine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.36e-05	0.000589	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	1.33e-05	0.000579	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.33e-05	0.000578	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.32e-05	0.000573	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.32e-05	0.000573	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.32e-05	0.000573	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.31e-05	0.00057	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.31e-05	0.000569	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.31e-05	0.000569	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.31e-05	0.000567	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.3e-05	0.000565	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.3e-05	0.000564	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.3e-05	0.000563	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.3e-05	0.000563	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.29e-05	0.000561	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.29e-05	0.00056	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.29e-05	0.000559	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.28e-05	0.000557	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.27e-05	0.000552	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.27e-05	0.000549	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.25e-05	0.000544	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.25e-05	0.000541	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.22e-05	0.00053	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.22e-05	0.00053	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.22e-05	0.000528	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.2e-05	0.000521	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.2e-05	0.000521	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.2e-05	0.000519	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.2e-05	0.000518	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.19e-05	0.000518	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.19e-05	0.000517	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.19e-05	0.000515	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.18e-05	0.000514	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.18e-05	0.000513	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.18e-05	0.000512	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.18e-05	0.000511	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.18e-05	0.000511	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.18e-05	0.000511	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.18e-05	0.00051	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.17e-05	0.000509	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.17e-05	0.000509	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.17e-05	0.000509	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.17e-05	0.000506	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.16e-05	0.000502	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.12e-05	0.000487	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.12e-05	0.000487	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.12e-05	0.000487	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.1e-05	0.000477	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.09e-05	0.000472	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.08e-05	0.00047	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.08e-05	0.00047	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.08e-05	0.000469	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.08e-05	0.000469	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.08e-05	0.000466	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.06e-05	0.00046	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.06e-05	0.000459	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.04e-05	0.000449	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.04e-05	0.000449	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.02e-05	0.000442	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.02e-05	0.000442	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.02e-05	0.000441	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.02e-05	0.000441	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.97e-06	0.000432	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.97e-06	0.000432	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.86e-06	0.000427	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.29e-06	0.000403	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.27e-06	0.000402	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.27e-06	0.000402	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.15e-06	0.000397	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.02e-06	0.000391	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.97e-06	0.000389	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.92e-06	0.000387	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.84e-06	0.000383	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.79e-06	0.000381	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.7e-06	0.000377	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.66e-06	0.000375	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.61e-06	0.000373	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.54e-06	0.00037	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.41e-06	0.000365	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.37e-06	0.000363	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.29e-06	0.000359	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.19e-06	0.000355	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.08e-06	0.00035	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.04e-06	0.000349	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.99e-06	0.000346	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.9e-06	0.000343	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.88e-06	0.000341	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.86e-06	0.000341	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.85e-06	0.00034	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.76e-06	0.000336	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.75e-06	0.000336	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.73e-06	0.000335	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.7e-06	0.000334	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.64e-06	0.000331	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.63e-06	0.000331	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.62e-06	0.00033	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.59e-06	0.000329	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.53e-06	0.000326	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.52e-06	0.000326	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.5e-06	0.000325	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.47e-06	0.000324	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.36e-06	0.000319	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.1e-06	0.000308	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.05e-06	0.000306	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.98e-06	0.000303	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.97e-06	0.000302	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.94e-06	0.000301	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.94e-06	0.000301	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.84e-06	0.000297	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.84e-06	0.000296	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.83e-06	0.000296	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.81e-06	0.000295	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.69e-06	0.00029	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.35e-06	0.000275	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.26e-06	0.000271	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.23e-06	0.00027	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.21e-06	0.000269	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	5.41e-06	0.000235	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.84e-06	0.00021	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.81e-06	0.000209	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.67e-06	0.000202	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.65e-06	0.000201	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.65e-06	0.000201	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.62e-06	0.0002	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.45e-06	0.000193	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.42e-06	0.000192	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.1e-06	0.000178	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.08e-06	0.000177	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.03e-06	0.000175	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.03e-06	0.000174	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.01e-06	0.000174	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4e-06	0.000174	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.95e-06	0.000171	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.93e-06	0.00017	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	3.83e-06	0.000166	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.74e-06	0.000162	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.68e-06	0.00016	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.67e-06	0.000159	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.65e-06	0.000158	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.53e-06	0.000153	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	3.5e-06	0.000152	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.84e-06	0.000123	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.74e-06	0.000119	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.73e-06	0.000118	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.61e-06	0.000113	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.41e-06	0.000104	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.37e-06	0.000103	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.37e-06	0.000103	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.32e-06	0.000101	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.31e-06	0.0001	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.16e-06	9.35e-05	CbGpPWpGaD
